Home | About RECERCAT | Contact
Català | Castellano

All of RECERCAT

By Communities &
Collections By Defense Date By Authors By Titles By Subject

This Collection

By Defense Date By Authors By Titles By Subject 

Statistics

View Statistics All RECERCAT

My RECERCAT

Login E-mail Alerts
Other repositories directory 
RECERCAT Home > Universitat de Barcelona > Medicina > Articles publicats en revistes (Medicina) > View document

To access the full text documents, please follow this link: http://hdl.handle.net/2445/121235

dc.contributor Universitat de Barcelona
dc.contributor.author Llovet i Bayer, Josep Maria
dc.contributor.author Johnson, Philip J.
dc.date 2018-04-03T15:28:46Z
dc.date 2018-04-03T15:28:46Z
dc.date 2014-03-20
dc.date 2018-04-03T15:28:46Z
dc.identifier.citation 0732-183X
dc.identifier.citation 645640
dc.identifier.uri http://hdl.handle.net/2445/121235
dc.format 2 p.
dc.format application/pdf
dc.language.iso eng
dc.publisher American Society of Clinical Oncology
dc.relation Reproducció del document publicat a: https://doi.org/10.1200/JCO.2013.54.3033
dc.relation Journal of Clinical Oncology, 2014, vol. 32, num. 9, p. 968-969
dc.relation https://doi.org/10.1200/JCO.2013.54.3033
dc.rights (c) American Society of Clinical Oncology, 2014
dc.rights info:eu-repo/semantics/openAccess
dc.subject Assaigs clínics de medicaments
dc.subject Càncer de fetge
dc.subject Drug testing
dc.subject Liver cancer
dc.title Reply to X. Qi et al ' Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?'
dc.type info:eu-repo/semantics/article
dc.type info:eu-repo/semantics/publishedVersion

Show simple item record

Related documents

Other documents of the same author

Reply to X. Qi et al ' Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?'
Llovet i Bayer, Josep Maria; Johnson, Philip J.
Search: A phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma
Zhu, Andrew X.; Rosmorduc, Olivier; Evans, T.R. Jeffry; Ross, Paul J.; Santoro, Armando; Carrilho, Flair Jose; Bruix Tudó, Jordi; Qin, Shukui; Thuluvath, Paul J.; Llovet i Bayer, Josep Maria; Leberre, Marie-Aude; Jensen, Markus; Meinhardt, Gerold; Kang, Yoon-Koo
DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma
Villanueva, Augusto; Portela, Anna; Sayols, Sergi; Battiston, Carlo; Hoshida, Yujin; Méndez-González, Jesús; Imbeaud, Sandrine; Letouzé, Eric; Hernández Gea, Virginia; Cornella, Helena; Pinyol, Roser; Solé Arqués, Manuel; Fuster Obregón, Josep; Zucman-Rossi, Jessica; Mazzaferro, Vincenzo; Esteller, Manel; Llovet i Bayer, Josep Maria; HEPTROMIC Consortium
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials
Montal, Robert; Andreu Oller, Carmen; Bassaganyas, Laia; Esteban Fabró, Roger; Moran, Sebastian; Montironi, Carla; Moeini, Agrin; Pinyol, Roser; Peix, Judit; Cabellos, Laia; Villanueva, Augusto; Sia, Daniela; Mazzaferro, Vincenzo; Esteller, Manel; Llovet i Bayer, Josep Maria
Unique genomic profile of fibrolamellar hepatocellular carcinoma
Cornella, Helena; Alsinet, Clara; Sayols, Sergi; Zhang, Zhongyang; Hao, Ke; Cabellos, Laia; Hoshida, Yujin; Vila Casadesús, Maria; Villanueva, Augusto; Thung, Swan; Ward, Stephen C.; Rodríguez Carunchio, Leonardo.; Imbeaud, Sandrine; Lachenmayer, Anja; Quaglia, Alberto; Nagorney David M.; Minguez, Beatriz; Carrilho, Flair; Robert, Lewis R.; Mazzaferro, Vincenzo; Schwartz, Myron; Esteller, Manel; Heaton, Nigel D.; Zucman-Rossi, Jessica; Llovet i Bayer, Josep Maria
Accesibility | Legal note | Cookies Policy
 

Coordination

 

Supporters